Literature DB >> 21150634

Impact of depression treatment on mental and physical health-related quality of life of cardiac patients: a meta-analysis.

Adrienne O'Neil1, Kristy Sanderson, Brian Oldenburg, C Barr Taylor.   

Abstract

PURPOSE: : To conduct a meta-analysis evaluating the effectiveness of depression treatment on mental and physical health-related quality of life (HRQOL) of cardiac patients.
METHODS: : Studies were identified using medical, health, psychiatry, psychology, and social sciences databases. Inclusion criteria were (1) 1 or more control conditions, (2) random assignment to condition after admission for myocardial infarction (MI)/acute coronary syndrome, after recording positive results on a depression screener, (3) documentation of depression symptoms at baseline, (4) depression management as a component of the rehabilitation/intervention, (5) validated measure of HRQOL as an outcome, at minimum 6-month followup. For meta-analysis, mental and physical HRQOL were the end points studied, using standardized mean differences for continuous outcome measures, with 95% confidence intervals. Heterogeneity was explored by calculating I statistic.
RESULTS: : Five randomized controlled trials included in the analysis represented 2105 participants (1058 intervention vs 1047 comparator). Compared with a comparator group at 6 months, a test for overall effect demonstrated statistically significant improvements in mental HRQOL in favor of the intervention (standardized mean differences = -0.29 [-0.38 to -0.20], [P < .00001]; I = 0%). Depression treatment had a modest yet significant impact on physical HRQOL (standardized mean differences = -0.14 [-0.24 to -0.04] [P = .009]; I = 15%).
CONCLUSION: : While the impact of post-MI depression interventions on physical HRQOL is modest, treatment can improve mental HRQOL in a significant way. Future research is required to develop and evaluate a program that can achieve vital improvements in overall HRQOL, and potentially cardiovascular outcomes, of cardiac patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21150634     DOI: 10.1097/HCR.0b013e3181fc0985

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil Prev        ISSN: 1932-7501            Impact factor:   2.081


  6 in total

1.  The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma.

Authors:  Casey A Boyd; Jaime Benarroch-Gampel; Kristin M Sheffield; Yimei Han; Yong-Fang Kuo; Taylor S Riall
Journal:  Surgery       Date:  2012-09       Impact factor: 3.982

2.  Depression treatment and health-related quality of life among adults with diabetes and depression.

Authors:  Ebtihag O Alenzi; Usha Sambamoorthi
Journal:  Qual Life Res       Date:  2015-11-21       Impact factor: 4.147

3.  Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.

Authors:  Larry K Brown; Betsy D Kennard; Graham J Emslie; Taryn L Mayes; Laura B Whiteley; James Bethel; Jiahong Xu; Sarah Thornton; Mary R Tanney; Linda A Hawkins; Patricia A Garvie; Geetha A Subramaniam; Carol J Worrell; Laura W Stoff
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

4.  Racial/ethnic differences in health-related quality of life among Hawaii adult population.

Authors:  Eunjung Lim; James Davis; Chathura Siriwardhana; Lovedhi Aggarwal; Allen Hixon; John J Chen
Journal:  Health Qual Life Outcomes       Date:  2020-12-09       Impact factor: 3.186

5.  Randomised controlled trial of an automated, interactive telephone intervention (TLC Diabetes) to improve type 2 diabetes management: baseline findings and six-month outcomes.

Authors:  Emily D Williams; Dominique Bird; Andrew W Forbes; Anthony Russell; Susan Ash; Robert Friedman; Paul A Scuffham; Brian Oldenburg
Journal:  BMC Public Health       Date:  2012-08-03       Impact factor: 3.295

6.  Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial.

Authors:  Adrian Wells; Kirsten McNicol; David Reeves; Peter Salmon; Linda Davies; Anthony Heagerty; Patrick Doherty; Rebecca McPhillips; Rebecca Anderson; Cintia Faija; Lora Capobianco; Helen Morley; Hannah Gaffney; Gemma Shields; Peter Fisher
Journal:  Trials       Date:  2018-04-03       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.